XenoSTART
XenoSTART is an industry-leading oncology translational research organization dedicated to advancing drug development through clinically relevant preclinical cancer models. Built on START’s global network of community-based oncology centers, XenoSTART offers one of the largest and most deeply characterized catalogs of PDX models in the industry, with more than 2,800 models spanning a broad range of tumor types and disease stages. All of its models are sourced from patients enrolled in clinical trials at START sites and are annotated with rich clinical histories, molecular profiling, and in vivo drug response data, enabling sponsors to design smarter studies, test combinations that mirror real-world biology, and generate decision-quality data earlier in development.
